GLP-1 Market
LLY $1184.63 ▼ -0.0% NVO $38.31 ▼ -1.0% PFE $28.72 • 0.0% VKTX $31.81 ▼ -3.7% KLRA $10.99 ▼ -1.2% GPCR $32.69 ▼ -6.8% RHHBY $52.25 ▼ -2.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Usual insulin treatment

Company
Centre Hospitalier Universitaire Dijon
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 30, 2026

Find a Clinical Trial Near Me

See recruiting studies for Usual insulin treatment and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05305794

    Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

    Not yet reported Centre Hospitalier Universitaire Dijon 76 participants Est. completion 2028-08 1 site Added to GLP-1
    Other conditions: Double Diabetes
    View official trial listing →
  • Recruiting NCT NCT07240012

    Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes

    Not yet reported Rigshospitalet, Denmark 305 participants Est. completion 2028-10 8 sites
    Other conditions: Diabete Type 1, Pregnancy Complications
    View official trial listing →
  • Completed NCT NCT01269606

    Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 13 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT02064023

    Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy

    Not yet reported University of British Columbia 2 participants Est. completion 2015-12-04 2 sites
    Type 2 diabetes Other conditions: Type 1 Diabetes, Pregnancy
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.